Pfizer (PFE) Dividends Paid - Common (2009 - 2026)

Pfizer (PFE) has reported Dividends Paid - Common for 18 consecutive years, with $2.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Dividends Paid - Common changed 0.25% year-over-year to $2.5 billion in Q2 2026; TTM through Jun 2026 was $9.8 billion, a 32.02% decrease from a year earlier, with the FY2025 full-year figure at $9.8 billion, up 2.72% from the prior year.
• Dividends Paid - Common was $2.5 billion for Q2 2026 at Pfizer, roughly flat from $2.4 billion in the prior quarter.
• Over five years, Dividends Paid - Common peaked at $7.1 billion in Q3 2024 and troughed at $2.2 billion in Q3 2022.
• A 5-year average of $2.7 billion and a median of $2.4 billion in 2024 frame the typical range for Dividends Paid - Common.
• Across the five-year window, Dividends Paid - Common climbed 3.55% in 2022 and slumped 65.73% in 2025, its largest moves.
• Over 5 years, Dividends Paid - Common stood at $2.2 billion in 2022, then gained by 3.16% to $2.3 billion in 2023, then jumped by 208.08% to $7.1 billion in 2024, then sank by 65.72% to $2.4 billion in 2025, then rose by 0.25% to $2.5 billion in 2026.
• The last three Dividends Paid - Common figures came in at $2.5 billion (Q2 2026), $2.4 billion (Q1 2026), and $2.4 billion (Q4 2025), per Business Quant data.